Quibim’s flagship solution, which uses biopsy data for training ... cancer detection and treatment. QP-Prostate, which uses algorithms trained on actual pathology data as ground truth, already ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

This could potentially be used as a standalone pan-cancer test or, given its low false positive rate among healthy people, be licensed out for use in conjunction with other liquid biopsy ...

To better understand the risks and uncertainties that could cause actual ... approach in prostate cancer, which has enabled us to go from an early beginning in RP only to adding biopsy almost ...

These statements are based on management's current expectations, and the actual ... For prostate cancer, Myriad is a leader for diagnostic testing at the time of biopsy with Prolaris, which ...

To better understand the risks and uncertainties that could cause actual ... approach in prostate cancer, which has enabled us to go from an early beginning in RP only to adding biopsy almost ...

Interim CEO Ron Sargent is in and we're only focused on the future. Did you find that odd? What did you make of Kroger's ...